ArticlemAbs

Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.

Abdullah Elsayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.